Specialty Pharmaceuticals Industry Financials, Performance and Ratios
-
Industry Score
18.0 /100
Rank 115 out of 131 Industries -
Advance/Decline
9/18
-
No. of Companies27
-
Avg. Market Cap1,945
-
Price to Earning Ratio6.40
-
Price to Earning Growth Ratio0.17
-
Price to Book Ratio13.69
-
Return on Equity14.87
-
Return on Capital Employed-
-
Return on Assets23.24
-
Dividend yield 1 year %0.00
-
Net Profit Growth Annual YoY %-190.98 %
-
Net Profit Growth Qtr YoY %-187.22 %
-
Net Profit Growth Qtr QoQ %66.09 %
Show more
*All values are market cap weighted averages.
*All Financial parameters are in Million USD.
Specialty Pharmaceuticals Industry Market Breadth
- < -5%
- -2 to -5%
- 0 to -2%
- 0 to 2%
- 2 to 5%
- > 5%
Specialty Pharmaceuticals Peer comparison
Compare all stocks in Specialty Pharmaceuticals industry listed on stock exchanges
| Stock Name | 3M Price Chart | Market Cap | LTPLast Traded Price | Day High Low (%) | Week High Low (%) | Month High Low (%) | Qtr High Low(%) | 1 Year High low(%) | 3 Year High low(%) | 5 Year High low(%) | 10 Year High low(%) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Bausch Health Companies Inc |
|
2,356.1
|
6.3
|
L
 -0.2%
H
6.2
6.4
|
L
 4.3%
H
5.7
6.4
|
L
 10.7%
H
5.5
6.4
|
L
 27.8%
H
4.3
7.3
|
L
 4.8%
H
4.3
8
|
L
 -14.7%
H
4.0
11.5
|
L
 -77.9%
H
4.0
29.3
|
L
 -71.6%
H
4.0
34.8
|
| Bellring Brands Inc |
|
1,096.5
|
9.4
|
L
 4.9%
H
8.9
9.5
|
L
 10.3%
H
8.2
9.5
|
L
 3.7%
H
7.3
9.5
|
L
 -21.4%
H
7.3
14.2
|
L
 -71.6%
H
7.3
34.4
|
L
 -78.7%
H
7.3
80.7
|
L
 -61.4%
H
7.3
80.7
|
L
H
7.3
80.7
|
| Usana Health Sciences Inc |
|
287.1
|
15.5
|
L
 1.0%
H
15.2
15.9
|
L
 6%
H
14.5
16.0
|
L
 5.6%
H
14
16.0
|
L
 -31.4%
H
12.6
23.6
|
L
 -26.3%
H
12.6
23.6
|
L
 -72.4%
H
12.6
57.8
|
L
 -84.3%
H
12.6
104.0
|
L
 -78.9%
H
12.6
138.0
|
| Biondvax Pharma Ltd (ADR) |
|
-
|
0.8
|
L
 -16.7%
H
0.7
0.9
|
L
 -36.4%
H
0.7
1.8
|
L
 -50.7%
H
0.7
2.1
|
L
 200%
H
0.2
3.6
|
L
 -48.6%
H
0.2
3.6
|
L
 1.4%
H
0.2
6.2
|
L
 -96.6%
H
0.2
99
|
L
 -98.0%
H
0.2
620
|
| Niagen Bioscience Inc |
|
197.0
|
2.5
|
L
 -3.5%
H
2.5
2.6
|
L
 -7.4%
H
2.5
2.7
|
L
 -17%
H
2.5
3.1
|
L
 -26.8%
H
2.5
3.6
|
L
 -66.4%
H
2.5
8.0
|
L
 91.5%
H
1.3
14.7
|
L
 -60.8%
H
1.2
14.7
|
L
 -15.0%
H
1.2
23.7
|
| Cronos Grp Inc |
|
1,182.6
|
3.2
|
L
 0.3%
H
3.2
3.4
|
L
 -0.6%
H
3.2
3.4
|
L
 -2.4%
H
3.2
3.5
|
L
 16.7%
H
2.7
3.6
|
L
 29.4%
H
2.3
3.6
|
L
 70.7%
H
1.6
3.6
|
L
 -41.4%
H
1.6
6.8
|
L
 256.7%
H
0.3
25.1
|
| Enveric Biosciences Inc |
|
6.2
|
1.4
|
L
 -0.7%
H
1.4
1.4
|
L
 -4.8%
H
1.3
1.5
|
L
 -7.4%
H
1.3
1.7
|
L
 1.5%
H
1.2
1.8
|
L
 -85.4%
H
1.2
13.3
|
L
 -99.6%
H
1.2
525.6
|
L
 -100.0%
H
1.2
20250
|
L
 -100.0%
H
1.2
12150000
|
| ZeroStack Corp |
|
87.2
|
4
|
L
 -5.2%
H
4
4.3
|
L
 -13.4%
H
3.9
4.6
|
L
 -3.6%
H
3.8
5.2
|
L
 113.9%
H
1.3
12.4
|
L
 -79.0%
H
1.3
19.7
|
L
 -89.4%
H
1.3
114.2
|
L
 -99.9%
H
1.3
4375.2
|
L
H
1.3
16731
|
| Jupiter Wellness Inc |
|
45.0
|
1.2
|
L
 0.8%
H
1.2
1.2
|
L
 -14.8%
H
1.1
1.6
|
L
 -5.5%
H
1.1
2.2
|
L
 -3.2%
H
0.9
2.2
|
L
 348.2%
H
0.1
7.2
|
L
 -11.7%
H
0.1
7.5
|
L
 -32.0%
H
0.1
7.5
|
L
H
0.1
8.9
|
| Lifevantage Corp |
|
75.5
|
6
|
L
H
5.9
6.1
|
L
H
5.3
6.1
|
L
 -2.9%
H
5.3
6.5
|
L
 -2.9%
H
5.3
7.0
|
L
 -33.1%
H
3.9
11.7
|
L
 -11.8%
H
3.9
27.4
|
L
 -12.0%
H
3.0
27.4
|
L
 -33.8%
H
2.9
27.4
|
| Mannatech Inc |
|
13.7
|
7.1
|
L
 -0.1%
H
7.0
7.5
|
L
 -9.4%
H
6.9
8.2
|
L
 -7.1%
H
6.1
8.3
|
L
 46.5%
H
4.0
9.7
|
L
 -19.8%
H
3.8
12.5
|
L
 -23.4%
H
3.8
16.5
|
L
 -79.9%
H
3.8
43.1
|
L
 -59.3%
H
3.8
49.1
|
| Natural Alternatives Intl Inc |
|
7.2
|
1.2
|
L
 2.7%
H
1.2
1.2
|
L
 0.9%
H
1.1
1.3
|
L
 -41.3%
H
1.1
2.1
|
L
 -49.1%
H
1.1
2.6
|
L
 -57.3%
H
1.1
5.0
|
L
 -82.0%
H
1.1
7.4
|
L
 -91.5%
H
1.1
15
|
L
 -91.3%
H
1.1
19.9
|
| Nature`s Sunshine Products Inc |
|
222.4
|
12.6
|
L
H
12.6
12.9
|
L
H
12
13.0
|
L
 -3.4%
H
12
13.7
|
L
 -40.7%
H
12
21.7
|
L
 -11.6%
H
12
28.1
|
L
 -24.1%
H
10.8
28.1
|
L
 -17.8%
H
7.9
28.1
|
L
 -16.3%
H
5.5
28.1
|
| Paranovus Entertainment Tech Ltd (Class A) |
|
2.6
|
3.0
|
L
 -7.3%
H
3.0
3.3
|
L
 -16.5%
H
3.0
3.6
|
L
 -23.4%
H
3.0
4.6
|
L
 -32.6%
H
3.0
9.7
|
L
 -100%
H
3.0
144000
|
L
 -100.0%
H
3.0
372120
|
L
 -100.0%
H
3.0
2736000
|
L
H
3.0
14640000
|
| PharmaCyte Biotech Inc |
|
3.7
|
0.3
|
L
 -5.6%
H
0.3
0.4
|
L
 -15%
H
0.3
0.4
|
L
 -19.1%
H
0.3
0.5
|
L
 -48.5%
H
0.3
0.7
|
L
 -65.3%
H
0.3
1.5
|
L
 -83.5%
H
0.3
2.6
|
L
 -88.8%
H
0.3
3.2
|
L
 -99.4%
H
0.3
253.4
|
| Revolution Medicines Inc |
|
38,143.3
|
178.0
|
L
 -6.0%
H
175.9
189.7
|
L
 -6.2%
H
175.9
197
|
L
 -9.2%
H
175.9
211.5
|
L
 -0.7%
H
175.9
224.3
|
L
 258.2%
H
52.4
224.3
|
L
 421.6%
H
15.5
224.3
|
L
 560.3%
H
14.1
224.3
|
L
H
14.1
224.3
|
| Scilex Holding Co |
|
19.9
|
2.8
|
L
 0.4%
H
2.8
2.9
|
L
 -3.1%
H
2.8
3.2
|
L
 -45.3%
H
2.8
5.6
|
L
 -67.8%
H
2.8
8.9
|
L
 -78.7%
H
2.8
27
|
L
 53.8%
H
0.2
34.3
|
L
 -71.8%
H
0.2
34.3
|
L
H
0.2
34.3
|
| Upexi Inc |
|
79.6
|
1.0
|
L
 -8.5%
H
1.0
1.1
|
L
 -11.8%
H
0.9
1.1
|
L
 -7.6%
H
0.9
1.3
|
L
 15.5%
H
0.7
1.3
|
L
 -82.7%
H
0.5
5.8
|
L
 -96.9%
H
0.5
33
|
L
 -99.2%
H
0.5
154
|
L
H
0.5
187.4
|
| Mira Pharma Inc |
|
26.5
|
0.6
|
L
 -4.6%
H
0.6
0.7
|
L
 -16%
H
0.6
0.8
|
L
 -12.5%
H
0.6
0.9
|
L
 -32.3%
H
0.6
1.1
|
L
 -65%
H
0.6
1.8
|
L
 -78.0%
H
0.5
6.4
|
L
H
0.5
8.0
|
L
H
0.5
8.0
|
| Scinai Immunotherapeutics Ltd (ADR) |
|
1.0
|
0.8
|
L
 -16.7%
H
0.7
0.9
|
L
 -36.4%
H
0.7
1.8
|
L
 -50.7%
H
0.7
2.1
|
L
 -70.5%
H
0.7
3.8
|
L
 -94.9%
H
0.7
15.5
|
L
 -99.0%
H
0.7
469
|
L
 -100.0%
H
0.7
3490
|
L
 -100.0%
H
0.7
62000
|
| Safety Shot Inc |
|
9.7
|
1.2
|
L
 0.8%
H
1.2
1.2
|
L
 -14.8%
H
1.1
1.6
|
L
 -5.5%
H
1.1
2.2
|
L
 -3.2%
H
0.9
2.2
|
L
 348.2%
H
0.1
7.2
|
L
 -11.7%
H
0.1
7.5
|
L
H
0.1
7.5
|
L
H
0.1
7.5
|
| FitLife Brands Inc |
|
78.8
|
8.4
|
L
 -2.2%
H
8.3
8.8
|
L
 -8.9%
H
8.3
9.8
|
L
 -10.0%
H
8.3
9.8
|
L
 -24.8%
H
8.3
11.6
|
L
 -55.1%
H
8.3
20.0
|
L
 -58.1%
H
8.3
35.5
|
L
 -49.3%
H
8.3
35.5
|
L
 -49.3%
H
8.3
35.5
|
| Agape ATP Corp |
|
1.6
|
1.6
|
L
 -6.0%
H
1.6
1.7
|
L
 -29.3%
H
1.6
2.9
|
L
 -31.7%
H
1.6
2.9
|
L
 -62.6%
H
1.6
4.0
|
L
 -97.5%
H
1.6
73.5
|
L
 -99.9%
H
1.6
1590
|
L
 -99.9%
H
1.6
1590
|
L
 -99.9%
H
1.6
1590
|
| Abivax (ADR) |
|
7,691.2
|
88.1
|
L
 -4.6%
H
86.9
91.5
|
L
 0.0%
H
84.5
92.8
|
L
 -13.8%
H
84.1
107.6
|
L
 -36.0%
H
84.1
138.4
|
L
 -5.1%
H
69.8
148.8
|
L
H
4.8
148.8
|
L
H
4.8
148.8
|
L
H
4.8
148.8
|
| ArriVent BioPharma Inc |
|
821.5
|
16.7
|
L
 -0.8%
H
16.5
17.2
|
L
 -0.4%
H
15.3
17.2
|
L
 -39.8%
H
11.4
31.5
|
L
 -49.2%
H
11.4
34
|
L
 -15.1%
H
11.4
35.8
|
L
H
11.4
36.2
|
L
H
11.4
36.2
|
L
H
11.4
36.2
|
| iBio Inc |
|
49.5
|
0.8
|
L
 -1.3%
H
0.8
0.8
|
L
 -11.5%
H
0.7
1.0
|
L
 -34.8%
H
0.7
1.4
|
L
 -43.0%
H
0.7
1.5
|
L
 -9.4%
H
0.7
3.8
|
L
 -3.8%
H
0.6
3.8
|
L
 -3.8%
H
0.6
3.8
|
L
 -3.8%
H
0.6
3.8
|
| Curanex Pharma Inc |
|
7.2
|
4.6
|
L
 -4.4%
H
4.6
5.0
|
L
 -13.0%
H
4.3
5.2
|
L
 10.3%
H
4.1
5.3
|
L
 2000%
H
0.2
6.8
|
L
 560%
H
0.2
6.8
|
L
 14.9%
H
0.2
9.2
|
L
 14.9%
H
0.2
9.2
|
L
 14.9%
H
0.2
9.2
|